<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> is a relatively uncommon disease and conventional management options include immunosuppressive drugs and/or haematopoeitic stem cell transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>It is now known that the pathogenesis of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> is immune mediated </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="168396">Mycophenolate</z:chebi> mofetil is a common immunosuppressive drug now used mainly in prophylaxis of graft rejection in organ transplant and also for prevention/treatment for <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft versus host disease</z:e> in haemtopoeitic stem cell transplantation </plain></SENT>
<SENT sid="3" pm="."><plain>It is thought that <z:chebi fb="0" ids="168396">mycophenolate</z:chebi> mofetil may be useful in this group of patients </plain></SENT>
<SENT sid="4" pm="."><plain>In this short report, <z:chebi fb="0" ids="168396">mycophenolate</z:chebi> mofetil was tried in 6 patients who had severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> with variable doses for a minimum duration of 9 months </plain></SENT>
<SENT sid="5" pm="."><plain>The result has however not been encouraging </plain></SENT>
</text></document>